NCT Number: NCT02144909
Partners in Care With Semi-Structured Support Group
The investigators are conducting a feasibility study using a randomized controlled trial (RCT) design in which participants will receive the Partners in Care (PIC) diabetes self-management intervention and then be randomized to either semi-structured social support or a standard follow-up control group. Participants in the support groups will receive a culturally-tailored, semi-structured social support program delivered in a community setting by trained community peer educators and other health professionals (e.g., pharmacist). The investigators believe that the addition of a semi-structured social support component as a supplement to an evidence-based diabetes self-management intervention will improve diabetes self-care maintenance.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Ke Ola Mamao, Honolulu, Hawaii, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Self-reported Native Hawaiian, Filipino, or other Pacific Islander ethnic background
- Adults age >18 years of age
- English-speaking
- Physician-diagnosed type 2 diabetes
- Baseline hemoglobin A1c >8%
Exclusion criteria
- Survival less than 6 months
- Planning to move out of the community during the intervention study period
- Pregnancy
- Any co-morbid condition (physical and mental disabilities) that would prevent the individual from participating in the intervention protocol (i.e., major psychiatric illness)
Treatment and study plan
Primary outcomes
-
Change from Baseline hemoglobin a1c at 3 months and at 6 months
Time frame: baseline, 3 months, 6 months
-
Change from Baseline diabetes management functioning as measured by the Problem Areas in Diabetes questionnaire at 3 months and 6 months
Time frame: baseline, 3 months, 6 months
The PAID is a 20-item instrument that assesses the physical and social functioning of patients as well as their perceived level of mental and emotional well-being specific to living with diabetes.
Secondary outcomes
-
Change from Baseline blood pressure at 3 months and 6 months
Time frame: baseline, 3 months, 6 months
-
Change from Baseline Total Cholesterol (including HDL and LDL) and triglycerides at 3 months and 6 months
Time frame: baseline, 3 months, 6 months
Total Cholesterol (including HDL and LDL) and triglycerides will be measured with the Cholestech LDX analyzer
-
Change from Baseline weight in kg at 3 months and 6 months
Time frame: baseline, 3 months, 6 months
Other outcomes
-
Change from Baseline reported diabetes self-care activities as measured by the Summary of Diabetes Self-Care Activities questionnaire at 3 months and 6 months
Time frame: baseline, 3 months, 6 months
-
Change from Baseline reported amount of support as measured a questionnaire at 3 months and 6 months
Time frame: baseline, 3 months, 6 months
-
Change from Baseline amount of physical activity as measured a questionnaire at 3 months and 6 months
Time frame: baseline, 3 months, 6 months
-
Change from Baseline dietary patterns as a questionnaire at 3 months and 6 months
Time frame: baseline, 3 months, 6 months
Sponsors and collaborators
Lead sponsor
University of Hawaii
Other
Collaborators
- National Institute on Minority Health and Health Disparities (NIMHD)
Registry information
Important dates
- Study start
- 2013
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- May 22, 2014
- Registry last updated
- Jun 3, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes
NCT06326047
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chula Vista, California, United States
View Trial DetailsEffect of Nicorandil in Type 2 Diabetic Obese Patients
NCT06423729
Body Weight, Diabetes Mellitus
Tanta, Egypt
View Trial DetailsThis Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus
NCT00418522
Diabetes Mellitus, Diabetes Mellitus, Type 2
Phoenix, Arizona, United States
View Trial DetailsA Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before
NCT04760626
Diabetes Mellitus, Diabetes Mellitus, Type 2
Birmingham, Alabama, United States
View Trial Details